April 23, 2013 – Oss, The Netherlands.  ModiQuest BV, a Dutch antibody drug development and diagnostics company focused on chronic inflammatory diseases, today announced the publication of novel therapeutic antibodies for the treatment of rheumatoid arthritis.  The results were published in the Journal of Clinical & Cellular Immunology 2013; S6: 006. doi: 10.4172/2155-9899.S6-006. In this … Continue reading